Attention-deficit/hyperactivity disorder (ADHD) extends beyond its classic presentation and often presents diagnostic and treatment challenges across the lifespan. This session reviews the evolving understanding of ADHD, including key diagnostic considerations, the neurobiology and pharmacology underlying current therapies, and practical approaches to individualized treatment selection. Learners will gain clinical pearls for recognizing complex presentations and applying current and emerging treatment strategies to optimize patient care.

Breakfast will be served. Seating is limited to 200 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Join your peers in the Exhibit Hall to learn about available pharmaceuticals and devices for clinical practice.

Despite strong evidence supporting their use, long-acting injectable antipsychotics remain underutilized in clinical practice. This session reviews patient selection, the pharmacologic principles behind LAIs, and practical approaches to initiating and integrating these therapies into routine care. Learners will gain clinical pearls for overcoming common barriers and optimizing treatment outcomes.

Psychedelic-assisted therapies are reshaping conversations around the treatment of major depressive disorder and represent one of the most rapidly evolving areas in psychiatry. This session explores the science behind psychedelics alongside other emerging therapeutic targets, reviewing their mechanisms of action, current evidence, and potential role in future clinical practice. Learners will gain practical strategies for evaluating these novel therapies and applying emerging evidence to patient care.

Lunch will be served. Seating is limited to 200 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Join your peers in the Exhibit Hall to learn about available pharmaceuticals and devices for clinical practice.

Early recognition of cognitive decline and effective management of agitation are essential skills in psychiatric practice. This session reviews the clinical features of cognitive impairment, key disease and pharmacologic considerations, and practical approaches to assessment and treatment. Learners will gain greater confidence in managing these complex clinical scenarios.

Join the Psych Congress Clinical Pearls Faculty, attendees, and peers for a poster reception with live music, hors d'oeuvres, and cocktails.

Medication-induced movement disorders are common in psychiatric practice but are often challenging to recognize and differentiate. This session reviews the distinguishing features of common movement disorders, the pharmacologic mechanisms that contribute to their development, and practical management strategies. Learners will gain confidence in making accurate diagnoses and selecting appropriate treatments.

Breakfast will be served. Seating is limited to 200 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Join your peers in the Exhibit Hall to learn about available pharmaceuticals and devices for clinical practice.

The treatment landscape for schizophrenia is expanding beyond traditional dopamine D2 receptor blockade, with muscarinic receptor-targeting therapies offering novel approaches to symptom management. This session will review the limitations of conventional antipsychotics, the science behind muscarinic receptor modulation, and the latest clinical data on available and emerging agents. Through expert insights and practical case-based discussion, participants will gain strategies for patient selection, treatment initiation, adverse effect management, and patient-centered communication to support the integration of these therapies into clinical practice.

Supported by an educational grant from Bristol-Myers Squibb.

Bipolar disorder frequently presents with clinical complexities that extend beyond guideline-based management. This session reviews challenging presentations, the pharmacologic principles that influence treatment selection, and current approaches to optimizing patient care. Learners will gain practical strategies for managing nuanced clinical situations encountered in everyday practice.

Lunch will be served. Seating is limited to 200 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Join your peers in the Exhibit Hall to learn about available pharmaceuticals and devices for clinical practice.

Treatment-resistant depression remains one of the most challenging conditions encountered in psychiatric practice and often requires thinking beyond standard treatment algorithms. This session reviews factors contributing to treatment resistance, practical pharmacologic strategies, and current and emerging treatment options. Learners will gain real-world approaches from experts in the field to care for patients with complex depression.